Go Pro
→ Your book is inside (From Profits Run) (Ad)tc pixel
NASDAQ:HYPR

Hyperfine Q2 2026 Earnings Report

Hyperfine logo
$0.98 -0.04 (-3.72%)
Closing price 04:00 PM Eastern
Extended Trading
$0.98 0.00 (-0.21%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Hyperfine EPS Results

Actual EPS
N/A
Consensus EPS
-$0.09
Beat/Miss
N/A
One Year Ago EPS
N/A

Hyperfine Revenue Results

Actual Revenue
N/A
Expected Revenue
$4.14 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Hyperfine Announcement Details

Quarter
Q2 2026
Date
8/12/2026
Time
After Market Closes
Conference Call Date
Wednesday, August 12, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

Hyperfine Earnings Headlines

Hyperfine, Inc.: Hyperfine Announces European Launch of Next-Generation Swoop System
July 1, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-07/68916985-hyperfine-inc-hyperfine-announces-european-launch-of-next-generation-swoop-system-004.htm
Hyperfine Announces European Launch of Next-Generation Swoop® System
July 1, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260701134409/en/hyperfine-announces-european-launch-of-next-generation-swoop%c2%ae-system/
Your money is changing
Porter Stansberry - who warned readers about Fannie Mae in 2006, called gold in 2008, and predicted COVID-era inflation - believes the U.S. dollar is undergoing its most significant reset since 1974. In a new documentary, Stansberry connects the tariffs, the Greenland obsession, the $1.4 trillion UAE deal, and disputes with China to what he calls Trump's New Dollar - and explains specific steps investors should take before a critical meeting of world leaders this December.tc pixel
July 16 at 1:00 AM  |  Porter & Company (Ad)
Hyperfine Inc - Ordinary Shares - Class A
June 23, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/hypr-hyperfine-inc-ordinary-shares-class-a
Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care
June 22, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260622808552/en/hyperfine-forms-global-neurosurgery-advisory-council-to-support-expansion-of-portable-mri-in-neurosurgical-care/
Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
June 18, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/06/18/10402316.htm
See More Hyperfine Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hyperfine? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hyperfine and other key companies, straight to your email.

About Hyperfine

Hyperfine (NASDAQ:HYPR) (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients. Hyperfine’s portable MRI is configured for rapid, point-of-care imaging of the brain and central nervous system, with applications spanning stroke evaluation, traumatic brain injury assessment and routine neurological monitoring. The system’s cloud-based image management and AI-assisted processing tools help streamline workflow and accelerate diagnostic decision-making.

Founded in 2014 and headquartered in Guilford, Connecticut, Hyperfine secured U.S. Food and Drug Administration 510(k) clearance for its portable MRI in 2020 and obtained CE mark authorization for its European operations in 2021. The company completed its business combination and began trading publicly on Nasdaq in 2022. Hyperfine continues to expand its commercial footprint across the United States and selective international markets, partnering with hospitals, health systems and research institutions to integrate portable MRI into standard clinical practice.

View Hyperfine Profile
Earnings Tools